Skip to Content

GS XJG (Tykerb 250 mg)

Generic Name: lapatinib

Pill with imprint GS XJG is Orange, Elliptical / Oval and has been identified as Tykerb 250 mg. It is supplied by GlaxoSmithKline.

Tykerb is used in the treatment of breast cancer, metastatic; breast cancer and belongs to the drug classes EGFR inhibitors, HER2 inhibitors. There is positive evidence of human fetal risk during pregnancy. Tykerb 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GS XJG

Tykerb

Generic Name
lapatinib
Imprint
GS XJG
Strength
250 mg
Color
Orange
Size
20.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
EGFR inhibitors, HER2 inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
GlaxoSmithKline
Inactive Ingredients
magnesium stearate, microcrystalline cellulose, povidone, sodium starch glycolate type A potato, FD&C Yellow No. 6, hypromelloses, polyethylene glycol, polysorbate 80, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00173-0752 GlaxoSmithKline
00078-0671 Novartis Pharmaceuticals Corporation

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.